What is Brightseed?
Founded in 2017 and headquartered in California, Brightseed operates at the intersection of artificial intelligence and biosciences. The company's core mission is to leverage advanced data analytics and biological insights to discover natural compounds that can significantly improve human health. By mapping the world's plant-based bioactives, Brightseed aims to unlock novel solutions for a range of health and wellness challenges, positioning itself as a key innovator in the rapidly evolving nutraceutical and biopharmaceutical industries. The company's AI-driven platform enables rapid identification and validation of these natural compounds, accelerating the path from discovery to application.
How much funding has Brightseed raised?
Brightseed has raised a total of $95M across 2 funding rounds:
Series A
$27M
Series B
$68M
Series A (2020): $27M with participation from Horizons Ventures, Lewis & Clark AgriFood Fund II, Seed 2 Growth Ventures, and CGC Ventures
Series B (2022): $68M led by Temasek
Key Investors in Brightseed
Horizons Ventures
Horizons Ventures is a global investment firm focused on deep science and technology aimed at advancing humanity, supporting innovative projects with transformative potential in science and technology sectors.
Lewis & Clark AgriFood Fund II
Lewis & Clark Partners is a growth equity fund specializing in the AgriFood sector, focusing on tech-enabled, sustainable companies and leveraging deep sector expertise to drive value creation.
Temasek
Temasek is a global investment company headquartered in Singapore, acting as a generational investor focused on making a difference with a long-term perspective.
What's next for Brightseed?
With its recent major strategic investment, Brightseed is poised for accelerated expansion and further development of its AI-powered discovery platform. The substantial capital infusion, totaling $95M, suggests the company is entering a scaling phase, likely focusing on expanding its research and development capabilities, forging strategic partnerships, and potentially bringing its discovered bioactives to market. This funding will be critical in solidifying Brightseed's position as a leader in the field of natural product discovery for human health, enabling deeper exploration of nature's potential to address global health needs.
See full Brightseed company page
